Oriola Oyj (HEL: OKDBV)

Market Cap	174.41M
Revenue (ttm)	1.56B
Net Income (ttm)	-23.30M
Shares Out	181.41M
EPS (ttm)	-0.13
PE Ratio	n/a
Forward PE	16.23
Dividend	0.07 (7.40%)
Ex-Dividend Date	Mar 20, 2024

Volume	48,385
Open	0.955
Previous Close	0.946
Day's Range	0.946 - 0.963
52-Week Range	0.850 - 1.174
Beta	0.62
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 30, 2024

About Oriola Oyj

Oriola Oyj provides healthcare and wellbeing products primarily in Sweden and Finland. It also offers vitamins, food and food supplements, sports nutrients, wound care, beauty, and makeup related products. In addition, it provides pharmaceutical logistics and dose dispensing services. Further, the company engages in the wholesale of traded goods and over-the counter products, and special licensed medicines; and provision of advisory services. The company serves pharmaceutical companies, pharmacies, veterinarians, and hospitals. Oriola Oyj was i...

• Industry: Pharmaceutical Retailers
• Sector: Healthcare
• Founded: 2006
• Employees: 815
• Stock Exchange: Nasdaq Helsinki
• Ticker Symbol: OKDBV

Financial Performance

In 2023, Oriola Oyj's revenue was 1.50 billion, a decrease of -2.90% compared to the previous year's 1.54 billion. Losses were -20.70 million, 762.5% more than in 2022.